ANSWER: Do not use if you have a history of multiple severe allergies or severe allergic reactions (anaphylaxis), or if you are allergic to the proteins (gram-positive bacterial proteins) used to make hyaluronic acid (HA) or to the lidocaine in this product.

ANSWER: Tell your provider if you are pregnant or breastfeeding. The safety of these products for use during pregnancy or while breastfeeding has not been studied.
The safety of JUVÉDERM VOLUMA XC in patients under 35 years or over 65 years has not been studied.
The safety and effectiveness of JUVÉDERM VOLUMA XC in areas other than the cheek area have not been established in clinical studies.
Tell your provider if you have a history of excessive scarring (eg, hypertrophic scarring and keloid formations) or pigmentation disorders, as use of these products may result in additional scars or changes in pigmentation.
Tell your doctor if you are planning other laser treatments or a chemical peel, as there is a possible risk of inflammation at the treatment site if these procedures are performed after treatment.
Patients who experience skin injury near the site of injection with these products may be at higher risk for side effects.
Tell your doctor if you are on immunosuppressive therapy used to decrease the body’s immune response, as use of these products may result in an increased risk of infection.
Tell your doctor if you are using medications that can prolong bleeding, such as aspirin, ibuprofen, or other blood thinners, as this may result in increased bruising or bleeding at the injection site.
Minimize strenuous exercise, exposure to extensive sun or heat, and alcoholic beverages within the first 24 hours following treatment.

ANSWER: The most common side effects include temporary reactions at the treatment site such as tenderness, swelling, firmness, lumps/bumps, bruising, pain, redness, discoloration, and itching. Side effects are moderate (uncomfortable) and generally last 2 to 4 weeks.
One of the risks with using this product is unintentional injection into a blood vessel, and while rare, the complications can be serious and may be permanent. These complications, which have been reported for facial injections, can include vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring.
As with all skin injection procedures, there is a risk of infection.

ANSWER: Do not use these products if you have a history of multiple severe allergies or severe allergic reactions (anaphylaxis), or if you are allergic to lidocaine or the gram-positive bacterial proteins used in these products.

ANSWER: Tell your provider if you are pregnant or breastfeeding. The safety of these products for use during pregnancy or while breastfeeding has not been studied.
The safety of JUVÉDERM XC and JUVÉDERM Ultra XC injectable gels in patients under 18 years, and the safety of JUVÉDERM VOLUMA XC in patients under 35 years or over 65 years has not been studied.
The safety and effectiveness of JUVÉDERM® XC for areas other than facial wrinkles and folds, and JUVÉDERM® Ultra XC for areas other than the lips and perioral area for lip augmentation, or facial wrinkles and folds, have not been established in clinical studies.
The safety and effectiveness of JUVÉDERM VOLUMA XC in areas other than the cheek area have not been established in clinical studies.
Tell your doctor if you have a history of excessive scarring (eg, hypertrophic scarring and keloid formations) or pigmentation disorders, as use of these products may result in additional scars or changes in pigmentation.
Tell your doctor if you are planning other laser treatments or a chemical peel, as there is a possible risk of inflammation at the treatment site if these procedures are performed after treatment.
Patients who experience skin injury near the site of injection with these products may be at a higher risk for side effects.
Tell your doctor if you are on immunosuppressive therapy used to decrease the body’s immune response, as use of these products may result in an increased risk of infection.
Tell your doctor if you are using medications that can prolong bleeding, such as aspirin, ibuprofen, or other blood thinners, as this may result in increased bruising or bleeding at the injection site.
Minimize strenuous exercise, exposure to extensive sun or heat, and alcoholic beverages within the first 24 hours following treatment.

ANSWER: The most common side effects include tenderness, swelling, firmness, lumps/bumps, bruising, pain, redness, discoloration, and itching. With JUVÉDERM XC and JUVÉDERM Ultra XC injectable gels, most side effects are mild or moderate and last 14 days or less. For JUVÉDERM VOLUMA XC, side effects are moderate (uncomfortable) and last 2 to 4 weeks.
One of the risks with using this product is unintentional injection into a blood vessel, and while rare, the complications can be serious and may be permanent. These complications, which have been reported for facial injections, can include vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring.
As with all skin injection procedures, there is a risk of infection.

ANSWER: Do not use this product if you have a history of multiple severe allergies or severe allergic reactions (anaphylaxis), or if you are allergic to lidocaine or the Gram-positive bacterial proteins used in this product.

ANSWER: Tell your doctor if you are pregnant or breastfeeding. The safety of this product for use during pregnancy or while breastfeeding has not been studied.
The safety of JUVÉDERM VOLLURE™ XC in patients under 22 years has not been studied.
The safety and effectiveness of JUVÉDERM VOLLURE™ XC in areas other than facial wrinkles and folds have not been established in clinical studies.
Tell your doctor if you have a history of excessive scarring (eg, hypertrophic scarring and keloid formations) or pigmentation disorders, as use of this product may result in additional scars or changes in pigmentation.
Tell your doctor if you are planning other laser treatments or a chemical peel, as there is a possible risk of inflammation at the treatment site if these procedures are performed after treatment.
Patients who experience skin injury near the site of injection with this product may be at a higher risk for side effects.
Tell your doctor if you are on immunosuppressive therapy used to decrease the body’s immune response, as use of this product may result in an increased risk of infection.
Tell your doctor if you are using medications that can prolong bleeding, such as aspirin, ibuprofen, or other blood thinners, as this may result in increased bruising or bleeding at the injection site.
Minimize strenuous exercise, exposure to extensive sun or heat, and alcoholic beverages within the first 24 hours following treatment.

ANSWER: The most commonly reported side effects with JUVÉDERM VOLLURE™ XC injectable gel included injectionsite redness, swelling, pain, tenderness, firmness, lumps/bumps, bruising, discoloration, and itching. Most side effects were mild or moderate and lasted 14 days or less.
One of the risks with using this product is unintentional injection into a blood vessel, and, while rare, the complications can be serious and may be permanent. These complications, which have been reported for facial injections, can include vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring.
As with all skin injection procedures, there is a risk of infection.

ANSWER: Do not use this product if you have a history of multiple severe allergies or severe allergic reactions (anaphylaxis), or if you are allergic to lidocaine or Gram-positive bacterial proteins used in this product.

ANSWER: Tell your provider if you are pregnant or breastfeeding. The safety of JUVÉDERM VOLBELLA XC for use during pregnancy or while breastfeeding has not been studied.
The safety of JUVÉDERM VOLBELLA XC in patients under 22 years has not been studied.
The safety and effectiveness of JUVÉDERM VOLBELLA XC in areas other than the lips and perioral area have not been established in controlled clinical studies.
Tell your provider if you have a history of excessive scarring (eg, hypertrophic scarring and keloid formation) or pigmentation disorders, as use of JUVÉDERM VOLBELLA XC may result in additional scars or changes in pigmentation.
Tell your provider if you are planning other laser treatments or a chemical peel, as there is a possible risk of inflammation at the treatment site if these procedures are performed after treatment.
Tell your provider if you are on immunosuppressive therapy used to decrease the body’s immune response, as use of JUVÉDERM VOLBELLA XC may result in an increased risk of infection
Tell your provider if you are using medications that can prolong bleeding, such as aspirin, ibuprofen, or other blood thinners, as this may result in increased bruising or bleeding at the injection site.
Minimize strenuous exercise, exposure to extensive sun or heat, and alcoholic beverages within the first 24 hours following treatment.

ANSWER: The most common side effects included swelling, tenderness, bruising, firmness, lumps/bumps, redness, pain, discoloration, itching, and dryness. Most side effects were mild or moderate and lasted 30 days or less. One of the risks with using this product is unintentional injection into a blood vessel, and while rare, the complications can be serious and may be permanent. These complications, which have been reported for facial injections, can include vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring.
As with all skin injection procedures, there is a risk of infection.